chr8-19939214-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000522701.5(LPL):c.-218-9T>C variant causes a splice polypyrimidine tract, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
LPL
ENST00000522701.5 splice_polypyrimidine_tract, intron
ENST00000522701.5 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.9398
1
1
Clinical Significance
Conservation
PhyloP100: 4.07
Genes affected
LPL (HGNC:6677): (lipoprotein lipase) LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LPL | NM_000237.3 | upstream_gene_variant | ENST00000650287.1 | NP_000228.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LPL | ENST00000650287.1 | upstream_gene_variant | NM_000237.3 | ENSP00000497642 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 437924Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 229754
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
437924
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
229754
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 29, 2024 | Variant summary: LPL c.-227T>C (also reported as "T(-39)C") is located in the untranscribed region upstream of the LPL gene region. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.-227T>C has been reported in the literature in the heterozygous state in at least 1 individual affected with biochemical features consistent with carrier status for Familial Lipoprotein Lipase Deficiency (example, Yang_1995, Yang_1996). These data do not allow any conclusion about variant significance. Post-heparin LPL activity in patient cells was approximately half of normal levels, and in vitro experiments found that this variant disrupts the Oct-1 transcription factor binding site and reduces LPL promoter activity to <15% of controls in a THP-1 monocytic cell line, however the biological impact was not assessed in LPL-relevant cell lines (example, Yang_1995). The following publications have been ascertained in the context of this evaluation (PMID: 9017514, 7753827). ClinVar contains an entry for this variant (Variation ID: 1549). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Hyperlipidemia, familial combined, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | May 09, 1995 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.